{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:49:02Z","timestamp":1776127742098,"version":"3.50.1"},"reference-count":149,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The incidence of syphilis, gonorrhea, chlamydia, and herpes simplex has increased over the last decade, despite the numerous prevention strategies. Worldwide scientists report a surge in drug-resistant infections, particularly in immunocompromised patients. Antigenic variations in syphilis enable long-term infection, but benzathine penicillin G maintains its efficiency, whereas macrolides should be recommended with caution. Mupirocin and zoliflodacin were recently introduced as therapies against ceftriaxone-resistant gonococcus, which poses a larger global threat. The gastrointestinal and prostatic potential reservoirs of Chlamydia trachomatis may represent the key towards complete eradication. Similar to syphilis, macrolides resistance has to be considered in genital chlamydiosis. Acyclovir-resistant HSV may respond to the novel helicase-primase inhibitors and topical imiquimod, particularly in HIV-positive patients. Novel drugs can overcome these challenges while nanocarriers enhance their potency, particularly in mucosal areas. This review summarizes the most recent and valuable discoveries regarding the immunopathogenic mechanisms of these sexually transmitted infections and discusses the challenges and opportunities of the novel molecules and nanomaterials.<\/jats:p>","DOI":"10.3390\/ijms23073550","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T15:31:21Z","timestamp":1648222281000},"page":"3550","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Fascinating Molecular and Immune Escape Mechanisms in the Treatment of STIs (Syphilis, Gonorrhea, Chlamydia, and Herpes Simplex)"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0612-0102","authenticated-orcid":false,"given":"Lucian G.","family":"Scurtu","sequence":"first","affiliation":[{"name":"Department of Dermatology I, Colentina Clinical Hospital, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020125 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viorel","family":"Jinga","sequence":"additional","affiliation":[{"name":"Department of Urology, Clinical Hospital Prof. Dr. Th. Burghele, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 030167 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Simionescu","sequence":"additional","affiliation":[{"name":"Department of Dermatology I, Colentina Clinical Hospital, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020125 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/infdis\/jiz442","article-title":"Refocusing Research on Sexually Transmitted Infections","volume":"222","author":"Eisinger","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_2","unstructured":"(2021, November 15). Sexually Transmitted Disease Surveillance, Centers for Disease Control and Prevention, Available online: https:\/\/www.cdc.gov\/std\/stats17\/2017-STD-Surveillance-Report_CDC-clearance-9.10.18.pdf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2471\/BLT.19.237149","article-title":"Herpes simplex virus: Global infection prevalence and incidence estimates, 2016","volume":"98","author":"James","year":"2020","journal-title":"Bull. World Health Organ."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jtm\/taz101","article-title":"Antimicrobial resistance in sexually transmitted infections","volume":"27","author":"Tien","year":"2020","journal-title":"J. Travel Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1128\/IAI.00827-06","article-title":"Antigenic Variation of TprK V Regions Abrogates Specific Antibody Binding in Syphilis","volume":"74","author":"LaFond","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_6","first-page":"310","article-title":"The Cross-Talk between Spirochetal Lipoproteins and Immunity","volume":"5","author":"Ekelesidis","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/sti.2010.042648","article-title":"The Gonococcus fights back: Is this time a knock out?","volume":"86","author":"Lewis","year":"2010","journal-title":"Sex. Transm. Infect."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1071\/SH19023","article-title":"World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): Review of new data and evidence to inform international collaborative actions and research efforts","volume":"16","author":"Unemo","year":"2019","journal-title":"Sex. Health"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00284-021-02353-8","article-title":"Neisseria gonorrhoeae Antimicrobial Resistance: Past to Present to Future","volume":"78","author":"Aitolo","year":"2021","journal-title":"Curr. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2741\/4611","article-title":"Molecular mechanisms of Chlamydia trachomatis resistance to antimicrobial drugs","volume":"23","author":"Mestrovic","year":"2018","journal-title":"Front. Biosci."},{"key":"ref_11","first-page":"35","article-title":"One Face of Chlamydia trachomatis: The Infectious Elementary Body","volume":"412","author":"Hayward","year":"2018","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.12688\/f1000research.16157.1","article-title":"Clinical management of herpes simplex virus infections: Past, present, and future","volume":"7","author":"Whitley","year":"2018","journal-title":"F1000Research"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/CMR.16.1.114-128.2003","article-title":"Herpes Simplex Virus Resistance to Acyclovir and Penciclovir after Two Decades of Antiviral Therapy","volume":"16","author":"Bacon","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_14","first-page":"204","article-title":"Drug-resistant herpes simplex virus in HIV infected patients","volume":"16","author":"Lolis","year":"2008","journal-title":"Acta Dermatovenerol. Croat."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Osias, E., Hung, P., Giacani, L., Stafylis, C., Konda, K.A., Vargas, S.K., Reyes-D\u00edaz, E.M., Comulada, W.S., Haake, D.A., and Haynes, A.M. (2020). Investigation of syphilis immunology and Treponema pallidum subsp. pallidum biology to improve clinical management and design a broadly protective vaccine: Study protocol. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05141-0"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1126\/science.281.5375.375","article-title":"Complete Genome Sequence of Treponema pallidum, the Syphilis Spirochete","volume":"281","author":"Fraser","year":"1998","journal-title":"Science"},{"key":"ref_17","unstructured":"Radolf, J.D., and Lukehart, S.A. (2006). Immunology of Syphilis. Pathogenic Treponemes: Cellular and Molecular Biology, Caister Academic Press."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.micinf.2007.05.018","article-title":"Assessment of cell-surface exposure and vaccinogenic potentials of Treponema pallidum candidate outer membrane proteins","volume":"9","author":"Tomson","year":"2007","journal-title":"Microbes Infect."},{"key":"ref_19","unstructured":"Bennett, J.E., Dolin, R., and Blaser, M.J. (2014). Mandell, Douglas and Bennett\u2019s Principles and Practice of Infectious Diseases, Churchill Livingtone Elsevier."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.vetimm.2016.08.014","article-title":"Demonstration of the ability of a canine Lyme vaccine to reduce the incidence of histological synovial lesions following experimentally-induced canine Lyme borreliosis","volume":"180","author":"Grosenbaugh","year":"2016","journal-title":"Veter. Immunol. Immunopathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1002\/cpz1.44","article-title":"In Vitro Cultivation of the Syphilis Spirochete Treponema pallidum","volume":"1","author":"Edmondson","year":"2021","journal-title":"Curr. Protoc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nrmicro.2016.141","article-title":"Treponema pallidum, the syphilis spirochete: Making a living as a stealth pathogen","volume":"14","author":"Radolf","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/IAI.01666-06","article-title":"Phagocytosis of Borrelia burgdorferi and Treponema pallidum Potentiates Innate Immune Activation and Induces Gamma Interferon Production","volume":"75","author":"Moore","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1128\/IAI.01973-06","article-title":"CD4+ Lymphocytes and Gamma Interferon Predominate in Local Immune Responses in Early Experimental Syphilis","volume":"75","author":"Leader","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_25","first-page":"248","article-title":"Reinfection of chancre-immune rabbits with Treponema pallidum. I. Light and immunofluorescence studies","volume":"118","author":"Sell","year":"1985","journal-title":"Am. J. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1172\/JCI57173","article-title":"Syphilis: Using modern approaches to understand an old disease","volume":"121","author":"Ho","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-4939-9496-0_6","article-title":"Preparation of Lipooligosaccharide (LOS) from Neisseria gonorrhoeae","volume":"1997","author":"Christodoulides","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fimmu.2019.00321","article-title":"Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine","volume":"10","author":"Gulati","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1128\/iai.45.3.544-549.1984","article-title":"Heterogeneity of molecular size and antigenic expression within lipooligosaccharides of individual strains of Neisseria gonorrhoeae and Neisseria meningitidis","volume":"45","author":"Schneider","year":"1984","journal-title":"Infect. Immun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrmicro2713","article-title":"A bacterial siren song: Intimate interactions between Neisseria and neutrophils","volume":"10","author":"Criss","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_31","first-page":"1837","article-title":"Upregulation of ATF3 inhibits expression of the pro-inflammatory cytokine IL-6 duringNeisseria gonorrhoeaeinfection","volume":"15","author":"Calton","year":"2013","journal-title":"Cell. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"ftz008","DOI":"10.1093\/femspd\/ftz008","article-title":"Modelling the in-host dynamics of Neisseria gonorrhoeae infection","volume":"77","author":"Jayasundara","year":"2019","journal-title":"Pathog Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fimmu.2012.00011","article-title":"Contrasting Roles of IL-22 and IL-17 in Murine Genital Tract Infection by Neisseria gonorrhoeae","volume":"3","author":"Feinen","year":"2012","journal-title":"Front. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.3389\/fmicb.2018.02688","article-title":"The MtrCDE Efflux Pump Contributes to Survival of Neisseria gonorrhoeae From Human Neutrophils and Their Antimicrobial Components","volume":"9","author":"Handing","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/CMR.17.4.965-981.2004","article-title":"The Molecular Mechanisms Used by Neisseria gonorrhoeae To Initiate Infection Differ between Men and Women","volume":"17","author":"Edwards","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","article-title":"Transforming growth factor-beta regulation of immune responses","volume":"24","author":"Li","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e00095-11","DOI":"10.1128\/mBio.00095-11","article-title":"Diversion of the Immune Response to Neisseria gonorrhoeae from Th17 to Th1\/Th2 by Treatment with Anti-Transforming Growth Factor \u03b2 Antibody Generates Immunological Memory and Protective Immunity","volume":"2","author":"Liu","year":"2011","journal-title":"mBio"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.smim.2007.10.016","article-title":"Targeting the development and effector functions of TH17 cells","volume":"19","author":"Ghilardi","year":"2007","journal-title":"Semin. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Zhu, W., Ventevogel, M.S., Knilans, K.J., Anderson, J.E., Oldach, L.M., McKinnon, K.P., Hobbs, M.M., Sempowski, G.D., and Duncan, J.A. (2012). Neisseria gonorrhoeae Suppresses Dendritic Cell-Induced, Antigen-Dependent CD4 T Cell Proliferation. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0041260"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"127017","DOI":"10.1155\/2013\/127017","article-title":"Neisseria gonorrhoeaeInduces a Tolerogenic Phenotype in Macrophages to Modulate Host Immunity","volume":"2013","author":"Escobar","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_41","first-page":"2443","article-title":"Chlamydia trachomatis trachoma, perinatal infections, lymphogranuloma venereum, and other genital infections","volume":"72","author":"Stamm","year":"2010","journal-title":"Princ. Pract. Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1600-0897.2010.00819.x","article-title":"Chlamydia trachomatis, a Hidden Epidemic: Effects on Female Reproduction and Options for Treatment","volume":"63","author":"Carey","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.femsre.2005.03.002","article-title":"The chlamydial developmental cycle","volume":"29","author":"Abdelrahman","year":"2005","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1128\/IAI.69.9.5899-5904.2001","article-title":"Isolation and Characterization of a Mutant Chinese Hamster Ovary Cell Line That Is Resistant to Chlamydia trachomatis Infection at a Novel Step in the Attachment Process","volume":"69","author":"Carabeo","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1128\/IAI.66.3.1258-1260.1998","article-title":"Sulfated polysaccharides and a synthetic sulfated polymer are potent inhibitors of Chlamydia trachomatis infectivity in vitro but lack protective efficacy in an in vivo murine model of Chlamydial genital tract infection","volume":"66","author":"Su","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1128\/IAI.69.2.968-976.2001","article-title":"Infectivity of Chlamydia trachomatis Serovar LGV but Not E Is Dependent on Host Cell Heparan Sulfate","volume":"69","author":"Taraktchoglou","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/QCO.0000000000000804","article-title":"Rectal chlamydia infections: Implications for reinfection risk, screening, and treatment guidelines","volume":"35","author":"Lau","year":"2021","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e00203-17","DOI":"10.1128\/CVI.00203-17","article-title":"Chlamydia trachomatis: The Persistent Pathogen","volume":"24","author":"Witkin","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1099\/00221287-146-11-2723","article-title":"Closing in on Chlamydia and its intracellular bag of tricks","volume":"146","author":"Bavoil","year":"2000","journal-title":"Microbiology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1128\/iai.64.12.5366-5372.1996","article-title":"Vesicular interactions of the Chlamydia trachomatis inclusion are determined by chlamydial early protein synthesis rather than route of entry","volume":"64","author":"Scidmore","year":"1996","journal-title":"Infect. Immun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/JB.00065-18","article-title":"Impact of Active Metabolism on Chlamydia trachomatis Elementary Body Transcript Profile and Infectivity","volume":"200","author":"Grieshaber","year":"2018","journal-title":"J. Bacteriol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Tan, M., and Bavoil, P. (2012). Intracellular Pathogens I: Chlamydiales, American Society for Microbiology Press.","DOI":"10.1128\/9781555817329"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Murthy, A.K., Arulanandam, B.P., and Zhong, G. (2014). Chlamydia Vaccine: Progress and Challenges. Intracell. Pathog. Chlamydia I, 311\u2013333.","DOI":"10.1128\/9781555817329.ch14"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"a010256","DOI":"10.1101\/cshperspect.a010256","article-title":"Chlamydial Intracellular Survival Strategies","volume":"3","author":"Bastidas","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"11430","DOI":"10.1073\/pnas.0703218104","article-title":"Mechanisms of host cell exit by the intracellular bacterium Chlamydia","volume":"104","author":"Hybiske","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.micinf.2012.08.004","article-title":"Innate immune responses to Chlamydia pneumoniae infection: Role of TLRs, NLRs, and the inflammasome","volume":"14","author":"Shimada","year":"2012","journal-title":"Microbes Infect."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Scurtu, L.G., and Simionescu, O. (2021). Soluble Factors and Receptors Involved in Skin Innate Immunity\u2014What Do We Know So Far?. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121795"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.bbrc.2014.08.128","article-title":"Chlamydia pneumoniae harness host NLRP3 inflammasome-mediated caspase-1 activation for optimal intracellular growth in murine macrophages","volume":"452","author":"Itoh","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_59","first-page":"928","article-title":"Genital Herpes: A Review","volume":"93","author":"Groves","year":"2016","journal-title":"Am. Fam. Physician"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1086\/505359","article-title":"The Cycle of Human Herpes Simplex Virus Infection: Virus Transport and Immune Control","volume":"194","author":"Cunningham","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"8206","DOI":"10.1128\/JVI.01302-15","article-title":"Global Diversity within and between Human Herpesvirus 1 and 2 Glycoproteins","volume":"89","author":"Lamers","year":"2015","journal-title":"J. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/v4050800","article-title":"Herpes Virus Fusion and Entry: A Story with Many Characters","volume":"4","author":"Eisenberg","year":"2012","journal-title":"Viruses"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"E5688","DOI":"10.1073\/pnas.1411072112","article-title":"Licensed human natural killer cells aid dendritic cell maturation via TNFSF14\/LIGHT","volume":"111","author":"Holmes","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1128\/JVI.80.1.138-148.2006","article-title":"Soluble V domain of nectin-1\/HveC enables entry of herpes simplex virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein D","volume":"80","author":"Kwon","year":"2006","journal-title":"J. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.4049\/jimmunol.1700959","article-title":"HVEM Imprints Memory Potential on Effector CD8 T Cells Required for Protective Mucosal Immunity","volume":"199","author":"Desai","year":"2017","journal-title":"J. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jss.2019.07.009","article-title":"Herpes Virus Entry Mediator (HVEM): A Novel Potential Mediator of Trauma-Induced Immunosuppression","volume":"245","author":"Wakeley","year":"2020","journal-title":"J. Surg. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3390\/v1030979","article-title":"Innate and Adaptive Immune Responses to Herpes Simplex Virus","volume":"1","author":"Chew","year":"2009","journal-title":"Viruses"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s13365-013-0189-3","article-title":"Immunological control of herpes simplex virus infections","volume":"19","author":"Egan","year":"2013","journal-title":"J. Neurovirol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4049\/jimmunol.179.1.322","article-title":"Psychological Stress Compromises CD8+T Cell Control of Latent Herpes Simplex Virus Type 1 Infections","volume":"179","author":"Freeman","year":"2007","journal-title":"J. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/gene.2015.46","article-title":"Mutations in the TLR3 signaling pathway and beyond in adult patients with herpes simplex encephalitis","volume":"16","author":"Mork","year":"2015","journal-title":"Genes Immun."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/jdv.16946","article-title":"2020 European guideline on the management of syphilis","volume":"35","author":"Janier","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/0956462415624059","article-title":"UK national guidelines on the management of syphilis","volume":"27","author":"Kingston","year":"2016","journal-title":"Int. J. STD AIDS"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1017\/S0950268814002830","article-title":"Syphilis: Antibiotic treatment and resistance","volume":"143","author":"Stamm","year":"2015","journal-title":"Epidemiol. Infect."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4269\/ajtmh.15-0316","article-title":"Macrolide Resistance in the Syphilis Spirochete, Treponema pallidum ssp. pallidum: Can We Also Expect Macrolide-Resistant Yaws Strains?","volume":"93","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_75","first-page":"120","article-title":"P229 Prevalence of macrolide and tetracycline resistant Treponema pallidum strains in syphilis cases","volume":"97","author":"Eguiluz","year":"2021","journal-title":"PeruSex. Transm. Infect."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2340\/00015555-3589","article-title":"Surveillance of Antibiotic Resistance Genes in Treponema Pallidum Subspecies Pallidum from Patients with Early Syphilis in France","volume":"100","author":"Sanchez","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/AAC.01095-09","article-title":"Global Challenge of Antibiotic-Resistant Treponema pallidum","volume":"54","author":"Stamm","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.OLQ.0000114941.37942.4C","article-title":"Relapse of secondary syphilis after benzathine penicillin G: Molecular analysis","volume":"31","author":"Myint","year":"2004","journal-title":"Sex. Transm. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Cruz, A.R. (2010). Secondary Syphilis in Cali, Colombia: New Concepts in Disease Pathogenesis. PLoS Neglected Trop. Dis., 4.","DOI":"10.1371\/journal.pntd.0000690"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/1753425920952840","article-title":"Syphilitic infection impairs immunity by inducing both apoptosis and pyroptosis of CD4+ and CD8+ T lymphocytes","volume":"27","author":"Xia","year":"2021","journal-title":"Innate Immun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.4049\/jimmunol.1100615","article-title":"TpF1 fromTreponema pallidumActivates Inflammasome and Promotes the Development of Regulatory T Cells","volume":"187","author":"Babolin","year":"2011","journal-title":"J. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"18785","DOI":"10.1038\/srep18785","article-title":"Treponema pallidum (syphilis) antigen TpF1 induces angiogenesis through the activation of the IL-8 pathway","volume":"6","author":"Pozzobon","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Unemo, M., Ross, J., Serwin, A.B., Gomberg, M., Cusini, M., and Jensen, J.S. (2020). 2020 European guideline for the diagnosis and treatment of gonorrhoea in adults. Int. J. STD AIDS.","DOI":"10.1177\/0956462420949126"},{"key":"ref_84","first-page":"390","article-title":"The emergence of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone by transfer of resistance from an oral Neisseria subflava reservoir of resistance","volume":"77","author":"Kanesaka","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/22221751.2021.2011618","article-title":"Dissemination and genome analysis of high-level ceftriaxone-resistant penA 60.001 Neisseria gonorrhoeae strains from the Guangdong Gonococcal antibiotics susceptibility Programme (GD-GASP), 2016\u20132019","volume":"11","author":"Lin","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1080\/22221751.2020.1773325","article-title":"Impact of the gonococcal FC428 penA allele 60.001 on ceftriaxone resistance and biological fitness","volume":"9","author":"Zhou","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e01688-21","DOI":"10.1128\/aac.01688-21","article-title":"Increasing azithromycin resistance in Neisseria gonorrhoeae due to NG-MAST 12302 clonal spread in Canada, 2015\u20132018","volume":"66","author":"Sawatzky","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/mdr.2020.0594","article-title":"Large Increase in Azithromycin-Resistant Neisseria gonorrhoeae in Northern Spain","volume":"28","author":"Carballo","year":"2021","journal-title":"Microb. Drug Resist."},{"key":"ref_89","unstructured":"(2012). Cephalosporin-Resistant Neisseria gonorrhoeae Public Health Response Plan."},{"key":"ref_90","unstructured":"WHO (2021, December 15). Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery and Development of New Antibiotics, Available online: http:\/\/www.who.int\/medicines\/publications\/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/0956462415618837","article-title":"2015 European guideline on the management of Chlamydia trachomatis infections","volume":"27","author":"Lanjouw","year":"2016","journal-title":"Int. J. STD AIDS"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1128\/IAI.01244-13","article-title":"Hidden in Plain Sight: Chlamydial Gastrointestinal Infection and Its Relevance to Persistence in Human Genital Infection","volume":"82","author":"Rank","year":"2014","journal-title":"Infect. Immun."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.1128\/AAC.01405-13","article-title":"Differential Susceptibilities to Azithromycin Treatment of Chlamydial Infection in the Gastrointestinal Tract and Cervix","volume":"57","author":"Yeruva","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/jac\/dku574","article-title":"The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: A systematic review and meta-analysis","volume":"70","author":"Kong","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Craig, A.P., Kong, F.Y.S., Yeruva, L., Hocking, J.S., Rank, R.G., Wilson, D.P., and Donovan, B. (2015). Is it time to switch to doxycycline from azithromycin for treating genital chlamydial infections in women? Modelling the impact of autoinoculation from the gastrointestinal tract to the genital tract. BMC Infect. Dis., 15.","DOI":"10.1186\/s12879-015-0939-3"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12941-021-00465-4","article-title":"An overview of genes and mutations associated with Chlamydiae species\u2019 resistance to antibiotics","volume":"20","author":"Benamri","year":"2021","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijid.2020.03.015","article-title":"High treatment failure rate is better explained by resistance gene detection than by minimum inhibitory concentration in patients with urogenital Chlamydia trachomatis infection","volume":"96","author":"Shao","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_98","unstructured":"Elias, J., Frosch, M., and Vogel, U. (2011). Manual of Clinical Microbiology, ASM Press."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Ala-Almohadesin, A., Mohammadbeygi, M., Bahavar, A., Mohammadi, M.A., Mohamadzadeh, N., Abolhasani, M., and Dabiri, H. (2019). Molecular Detection of Pathogens Causing Sexually Transmissible Infections in Patients with Prostate Cancer and Hyperplasia by Quantitative TaqMan Real-Time PCR Assay. Clin. Lab., 65.","DOI":"10.7754\/Clin.Lab.2019.181243"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.12659\/MSM.893579","article-title":"Gonorrhea and Prostate Cancer Incidence: An Updated Meta-Analysis of 21 Epidemiologic Studies","volume":"21","author":"Lian","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/bjc.2011.271","article-title":"Prostate involvement during sexually transmitted infections as measured by prostate-specific antigen concentration","volume":"105","author":"Sutcliffe","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e13093","DOI":"10.1111\/and.13093","article-title":"Implications of prostate inflammation on male fertility","volume":"50","author":"Motrich","year":"2018","journal-title":"Andrologia"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jri.2013.05.002","article-title":"Chlamydia trachomatis infection of the male genital tract: An update","volume":"100","author":"Motrich","year":"2013","journal-title":"J. Reprod. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1093\/infdis\/jiab067","article-title":"Etiology and Diagnosis of Pelvic Inflammatory Disease: Looking Beyond Gonorrhea and Chlamydia","volume":"224","author":"Mitchell","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_105","first-page":"e11647","article-title":"Epidemiologic and Clinical Characteristics of Tubo-Ovarian Abscess, Hydrosalpinx, Pyosalpinx, and Oophoritis in Emergency Department Patients","volume":"1","author":"Mohseni","year":"2020","journal-title":"Cureus"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ajpath.2011.09.015","article-title":"Chlamydia trachomatis Disturbs Epithelial Tissue Homeostasis in Fallopian Tubes via Paracrine Wnt Signaling","volume":"180","author":"Kessler","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Smolarczyk, K., Mlynarczyk-Bonikowska, B., and Rudnicka, E. (2021). The Impact of Selected Bacterial Sexually Transmitted Diseases on Pregnancy and Female Fertility. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22042170"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Nelson, H.D., Zakher, B., Cantor, A., Deagas, M., and Pappas, M. (2014). Screening for Gonorrhea and Chlamydia: Systematic Review to Update the U.S. Preventive Services Task Force Recommendations.","DOI":"10.7326\/M14-1022"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e13091","DOI":"10.1111\/aji.13091","article-title":"Combining individualChlamydia trachomatisIgG antibodies MOMP, TARP, CPAF, OMP2, and HSP60 for tubal factor infertility prediction","volume":"81","author":"Land","year":"2019","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s12192-010-0171-4","article-title":"Immunopathogenic consequences of Chlamydia trachomatis 60 kDa heat shock protein expression in the female reproductive tract","volume":"15","author":"Linhares","year":"2010","journal-title":"Cell Stress Chaperones"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.fertnstert.2015.08.022","article-title":"Chlamydia trachomatis immunoglobulin G3 seropositivity is a predictor of reproductive outcomes in infertile women with patent fallopian tubes","volume":"104","author":"Steiner","year":"2015","journal-title":"Fertil. Steril."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1177\/0956462417727194","article-title":"2017 European guidelines for the management of genital herpes","volume":"28","author":"Patel","year":"2017","journal-title":"Int. J. STD AIDS"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jdcr.2021.05.001","article-title":"Treatment of acyclovir-resistant herpes simplex virus with intralesional cidofovir","volume":"13","author":"Enescu","year":"2021","journal-title":"JAAD Case Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1177\/09564624211006568","article-title":"Use of pritelivir in refractory aciclovir-resistant herpes simplex virus type 2","volume":"32","author":"Cannon","year":"2021","journal-title":"Int. J. STD AIDS"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"105190","DOI":"10.1016\/j.antiviral.2021.105190","article-title":"Helicase primase inhibitors (HPIs) are efficacious for therapy of human herpes simplex virus (HSV) disease in an infection mouse model","volume":"195","author":"Uhlig","year":"2021","journal-title":"Antivir. Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.abd.2020.10.019","article-title":"Acyclovir-resistant chronic mucocutaneous herpes with good response to the association with imiquimod in an AIDS patient: Case report","volume":"97","author":"Assoni","year":"2022","journal-title":"An. Bras. Dermatol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1590\/abd1806-4841.20198014","article-title":"Vegetative chronic genital herpes with satisfactory response to imiquimod","volume":"94","author":"Siqueira","year":"2019","journal-title":"An. Bras. Dermatol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"644664","DOI":"10.3389\/fimmu.2021.644664","article-title":"Herpes Simplex Virus 1 Infection of Neuronal and Non-Neuronal Cells Elicits Specific Innate Immune Responses and Immune Evasion Mechanisms","volume":"12","author":"Verzosa","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"12487","DOI":"10.1128\/JVI.79.19.12487-12494.2005","article-title":"Circularization of the Herpes Simplex Virus Type 1 Genome upon Lytic Infection","volume":"79","author":"Strang","year":"2005","journal-title":"J. Virol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1128\/JVI.01258-19","article-title":"The ICP0 Protein of Herpes Simplex Virus 1 (HSV-1) Downregulates Major Autophagy Adaptor Proteins Sequestosome 1 and Optineurin during the Early Stages of HSV-1 Infection","volume":"93","author":"Waisner","year":"2019","journal-title":"J. Virol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"22216","DOI":"10.1038\/s41598-020-77725-4","article-title":"Herpes simplex virus 1 targets IRF7 via ICP0 to limit type I IFN induction","volume":"10","author":"Shahnazaryan","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.virol.2018.07.011","article-title":"Strength in diversity: Understanding the pathways to herpes simplex virus reactivation","volume":"522","author":"Suzich","year":"2018","journal-title":"Virology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.virol.2021.02.011","article-title":"Anterograde transport of \u03b1-herpesviruses in neuronal axons","volume":"559","author":"DuRaine","year":"2021","journal-title":"Virology"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41586-021-04106-w","article-title":"Herpesviruses assimilate kinesin to produce motorized viral particles","volume":"599","author":"Pegg","year":"2021","journal-title":"Nature"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e01153-18","DOI":"10.1128\/mBio.01153-18","article-title":"Long-Term In Vitro Culture of the Syphilis Spirochete Treponema pallidum subsp. pallidum","volume":"9","author":"Edmondson","year":"2018","journal-title":"mBio"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"103281","DOI":"10.1016\/j.ebiom.2021.103281","article-title":"Efficacy of linezolid on Treponema pallidum, the syphilis agent: A preclinical study","volume":"65","author":"Haynes","year":"2021","journal-title":"EBioMedicine"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/cbdd.13899","article-title":"Discovery of novel antibacterial agents: Recent developments in D-alanyl-D-alanine ligase inhibitors","volume":"98","author":"Qin","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_128","first-page":"297","article-title":"In vitro cytotoxicity of salvicine, a novel diterpenoid quinone","volume":"20","author":"Qing","year":"1999","journal-title":"Zhongguo Yao Li Xue Bao."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Lichota, A., and Gwozdzinski, K. (2009). Anticancer Activity of Natural Compounds from Plant and Marine Environment. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113533"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1089\/omi.2014.0154","article-title":"Treponema pallidumPutative Novel Drug Target Identification and Validation: Rethinking Syphilis Therapeutics with Plant-Derived Terpenoids","volume":"19","author":"Dwivedi","year":"2015","journal-title":"OMICS"},{"key":"ref_131","first-page":"625","article-title":"Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): A randomised, non-inferiority trial","volume":"21","author":"Vries","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Cern, A., Bavli, Y., Hod, A., Zilbersheid, D., Mushtaq, S., Michael-Gayego, A., Barasch, D., Rotkopf, Y.F., Moses, A.E., and Livermore, D.M. (2021). Therapeutic Potential of Injectable Nano-Mupirocin Liposomes for Infections Involving Multidrug-Resistant Bacteria. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13122186"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1021\/acs.jpcb.1c08555","article-title":"Dynamics of the Catalytic Active Site of Isoleucyl tRNA Synthetase from Staphylococcus aureus bound with Adenylate and Mupirocin","volume":"126","author":"Chowdhury","year":"2022","journal-title":"J. Phys. Chem. B"},{"key":"ref_134","first-page":"e01808-18","article-title":"Single-Dose Phar-macokinetics, Excretion, and Metabolism of Zoliflodacin, a Novel Spiropyrimidinetrione Antibiotic, in Healthy Volunteers","volume":"63","author":"Lawrence","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jac\/dkab024","article-title":"High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018","volume":"76","author":"Unemo","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"682135","DOI":"10.3389\/fphar.2021.682135","article-title":"Pharmacodynamic Evaluation of Dosing, Bacterial Kill, and Resistance Suppression for Zoliflodacin Against Neisseria gonorrhoeae in a Dynamic Hollow Fiber Infection Model","volume":"12","author":"Jacobsson","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e0129221","DOI":"10.1128\/AAC.01292-21","article-title":"Thorough QT Study To Evaluate the Effect of Zoliflodacin, a Novel Therapeutic for Gonorrhea, on Cardiac Repolarization in Healthy Adults","volume":"65","author":"Newman","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e00863-20","DOI":"10.1128\/AAC.00863-20","article-title":"Susceptibility Trends of Zoliflodacin against Multidrug-Resistant Neisseria gonorrhoeae Clinical Isolates in Nanjing, China, 2014 to 2018","volume":"65","author":"Le","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/s41467-021-22012-7","article-title":"trans-Translation inhibitors bind to a novel site on the ribosome and clear Neisseria gonorrhoeae in vivo","volume":"12","author":"Aron","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/jcmm.17069","article-title":"Chlamydia trachomatis induces lncRNA MIAT upregulation to regulate mitochondria-mediated host cell apoptosis and chlamydial development","volume":"26","author":"Luo","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3389\/fmicb.2019.00943","article-title":"Elaborations on Corallopyronin A as a Novel Treatment Strategy Against Genital Chlamydial Infections","volume":"10","author":"Loeper","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ijantimicag.2018.07.025","article-title":"Effective inhibition of rifampicin-resistant Chlamydia trachomatis by the novel DNA-dependent RNA polymerase inhibitor corallopyronin A","volume":"52","author":"Shima","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/s41598-018-36601-y","article-title":"Autophagy induction and PDGFR-\u03b2-knockdown by siRNA-encapsulated nanoparticles reduce chlamydia trachomatis infection","volume":"9","author":"Yang","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"e01826-20","DOI":"10.1128\/AAC.01826-20","article-title":"Gylfe \u00c5sa A 2-Pyridone Amide Inhibitor of Transcriptional Activity in Chlamydia trachomatis","volume":"65","author":"Bahnan","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Sureram, S., Arduino, I., Ueoka, R., Ritt\u00e0, M., Francese, R., Srivibool, R., Darshana, D., Piel, J., Ruchirawat, S., and Muratori, L. (2022). The Peptide A-3302-B Isolated from a Marine Bacterium Micromonospora sp. Inhibits HSV-2 Infection by Preventing the Viral Egress from Host Cells. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020947"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"van de Sand, L., Bormann, M., Schmitz, Y., Heilingloh, C.S., Witzke, O., and Krawczyk, A. (2021). Antiviral Active Compounds Derived from Natural Sources against Herpes Simplex Viruses. Viruses, 13.","DOI":"10.3390\/v13071386"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/2589977512999201124121931","article-title":"Novel Applications of Nanotechnology in Controlling HIV and HSV Infections","volume":"13","author":"Akilesh","year":"2021","journal-title":"Curr. Drug. Res. Rev."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"119676","DOI":"10.1016\/j.ijpharm.2020.119676","article-title":"Acyclovir-loaded sulfobutyl ether-\u03b2-cyclodextrin decorated chitosan nanodroplets for the local treatment of HSV-2 infections","volume":"587","author":"Donalisio","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Chindamo, G., Sapino, S., Peira, E., Chirio, D., and Gallarate, M. (2021). Recent Advances in Nanosystems and Strategies for Vaginal Delivery of Antimicrobials. Nanomaterials, 11.","DOI":"10.3390\/nano11020311"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/7\/3550\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:42:39Z","timestamp":1760136159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/7\/3550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":149,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["ijms23073550"],"URL":"https:\/\/doi.org\/10.3390\/ijms23073550","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]}}}